An additive manufacturing software startup already working of Formula 1 racing teams has raised one million pounds in seed capital. Imperial College spin-out TOffeeAM optimises 3D printing product designs. Additive manufacturing is also referred to as 3D printing.
The latest funding will be utilized to hire experts and extra staff to grow upon the present engineering potential of TOffeeAM and increase its client base. This currently comprises Baker Hughes, GE Aviation, and a Formula 1 motor racing team.
The firm was established in 2019 at Imperial College London by Audrey Gaymann, CTO, CEO, Francesco Montomoli, and Marco Pietropaoli, COO, and is dependent on four years of study at Imperial College.
Currently the firm licenses its software, TOffee, to startups utilizing additive manufacturing in the areas of the automotive and aeronautics sectors.
Francesco Montomoli , the Founder and CEO of TOffeeAM, stated this: “This funding will give TOffeeAM the opportunity to continue our success at speeding up 3D printing across all industries by up to 20 times faster and to expand our team with expert engineers and other team members, and continue to scale the solution to serve our rapidly expanding customer base.”
The series of investments was directed by IQ Capital, together with the Royal Academy of Engineering and Imperial College London’s Techcelerate project.
In other news
In an innovative latest research, experts at the University of Minnesota have additively manufactured a working centimeter-scale heart pump of a human in the laboratory. The innovation could have a key hint for studying heart illness, the top cause of death in the US killing over 600,000 people every year.
The research is posted and is shown on Circulation Research’s cover, a publication of the American Heart Association.
Previously, the expats have made efforts to additively manufacture heart muscle cells or cardiomyocytes, that originated from what is known as pluripotent human stem cells. These are cells with the ability to create into any all kinds of cells in the body. Experts would reprogram the stem cells to heart muscle cells. After that, they would utilize specialized 3D printing machins to print them in a 3-dimensional form, referred to as an extracellular matrix.
The issue is that the scientist could at no point attain crucial cell density so as the heart muscle cells can work.
In the latest research, University of Minnesota experts flipped the process and it was successful.
“At first, we tried 3D printing cardiomyocytes, and we failed, too,” explains Brenda Ogle, the lead expert on the research and head of the Department of Biomedical Engineering in the University of Minnesota College of Science and Engineering.
“So with our team’s expertise in stem cell research and 3D printing, we decided to try a new approach. We optimized the specialized ink made from extracellular matrix proteins, combined the ink with human stem cells and used the ink-plus-cells to 3D print the chambered structure. The stem cells were expanded to high cell densities in the structure first, and then we differentiated them to the heart muscle cells.”